应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NRSN Neurosense Therapeutics Ltd
休市中 05-02 16:00:00 EDT
1.03
-0.01
-0.75%
盘后
1.03
+0.00
0.00%
16:13 EDT
最高
1.03
最低
0.9900
成交量
9.09万
今开
1.02
昨收
1.04
日振幅
3.85%
总市值
2,471万
流通市值
1,228万
总股本
2,399万
成交额
9.15万
换手率
0.76%
流通股本
1,193万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Neurosense Therapeutics Ltd.盘中异动 股价大跌5.94%报0.950美元
市场透视 · 04-23
Neurosense Therapeutics Ltd.盘中异动 股价大跌5.94%报0.950美元
Neurosense Therapeutics Ltd.盘中异动 早盘股价大跌7.41%
市场透视 · 04-15
Neurosense Therapeutics Ltd.盘中异动 早盘股价大跌7.41%
Neurosense Therapeutics Ltd.盘中异动 临近收盘股价大涨8.22%报1.070美元
市场透视 · 04-11
Neurosense Therapeutics Ltd.盘中异动 临近收盘股价大涨8.22%报1.070美元
Neurosense Therapeutics Ltd.盘中异动 急速拉升8.18%
市场透视 · 03-05
Neurosense Therapeutics Ltd.盘中异动 急速拉升8.18%
Neurosense Therapeutics Ltd.盘中异动 临近收盘快速下跌5.19%报1.05美元
市场透视 · 03-03
Neurosense Therapeutics Ltd.盘中异动 临近收盘快速下跌5.19%报1.05美元
Neurosense Therapeutics Ltd.盘中异动 快速上涨5.61%报1.13美元
市场透视 · 02-28
Neurosense Therapeutics Ltd.盘中异动 快速上涨5.61%报1.13美元
Neurosense Therapeutics Ltd.盘中异动 快速跳水5.60%报1.02美元
市场透视 · 02-25
Neurosense Therapeutics Ltd.盘中异动 快速跳水5.60%报1.02美元
Neurosense Therapeutics Ltd.盘中异动 快速拉升5.63%
市场透视 · 02-18
Neurosense Therapeutics Ltd.盘中异动 快速拉升5.63%
Neurosense Therapeutics Ltd.盘中异动 股价大涨6.00%
市场透视 · 02-03
Neurosense Therapeutics Ltd.盘中异动 股价大涨6.00%
Neurosense Therapeutics Ltd.盘中异动 下午盘快速上涨5.63%
市场透视 · 01-31
Neurosense Therapeutics Ltd.盘中异动 下午盘快速上涨5.63%
Neurosense Therapeutics Ltd.盘中异动 下午盘股价大跌5.45%
市场透视 · 01-27
Neurosense Therapeutics Ltd.盘中异动 下午盘股价大跌5.45%
Neurosense Therapeutics Ltd.盘中异动 股价大跌6.19%报1.06美元
市场透视 · 01-24
Neurosense Therapeutics Ltd.盘中异动 股价大跌6.19%报1.06美元
Neurosense Therapeutics Ltd.盘中异动 临近收盘急速下挫5.31%报1.07美元
市场透视 · 01-22
Neurosense Therapeutics Ltd.盘中异动 临近收盘急速下挫5.31%报1.07美元
Neurosense Therapeutics Ltd.盘中异动 早盘大幅下跌5.36%报1.06美元
市场透视 · 01-17
Neurosense Therapeutics Ltd.盘中异动 早盘大幅下跌5.36%报1.06美元
Neurosense Therapeutics Ltd.盘中异动 急速拉升5.31%报1.09美元
市场透视 · 01-16
Neurosense Therapeutics Ltd.盘中异动 急速拉升5.31%报1.09美元
Neurosense Therapeutics Ltd.盘中异动 股价大跌6.42%报1.11美元
市场透视 · 01-08
Neurosense Therapeutics Ltd.盘中异动 股价大跌6.42%报1.11美元
Neurosense Therapeutics Ltd.盘中异动 早盘快速拉升5.04%报1.25美元
市场透视 · 01-06
Neurosense Therapeutics Ltd.盘中异动 早盘快速拉升5.04%报1.25美元
Neurosense Therapeutics Ltd.盘中异动 股价大涨6.96%
市场透视 · 01-03
Neurosense Therapeutics Ltd.盘中异动 股价大涨6.96%
Neurosense Therapeutics Ltd.盘中异动 大幅下挫5.24%报1.18美元
市场透视 · 2024-12-31
Neurosense Therapeutics Ltd.盘中异动 大幅下挫5.24%报1.18美元
Neurosense Therapeutics Ltd.股价重挫19.49% 市值跌493.55万美元
市场透视 · 2024-12-23
Neurosense Therapeutics Ltd.股价重挫19.49% 市值跌493.55万美元
加载更多
公司概况
公司名称:
Neurosense Therapeutics Ltd
所属市场:
NASDAQ
上市日期:
--
主营业务:
NeuroSense Therapeutics Ltd.于2017年2月13日在以色列注册成立。该公司是一家临床阶段的生物技术公司,专注于发现和开发针对神经退行性疾病患者的治疗方法,包括肌萎缩性侧索硬化症(ALS)、阿尔茨海默病(AD)和帕金森病(PD)。公司的主要候选治疗药物PrimeC是一种新型的缓释口服制剂,由两种FDA批准的药物环丙沙星和塞来昔布组成的固定剂量组合。PrimeC旨在通过调节microRNA合成、铁积累和神经炎症来治疗ALS,所有这些都是ALS病理的标志。
发行价格:
--
{"stockData":{"symbol":"NRSN","market":"US","secType":"STK","nameCN":"Neurosense Therapeutics Ltd","latestPrice":1.03,"timestamp":1746216000000,"preClose":1.0378,"halted":0,"volume":90920,"hourTrading":{"tag":"盘后","latestPrice":1.03,"preClose":1.03,"latestTime":"16:13 EDT","volume":1,"amount":1.04,"timestamp":1746216821209},"delay":0,"floatShares":11925112,"shares":23988669,"eps":-0.548863,"marketStatus":"休市中","change":-0.0078,"latestTime":"05-02 16:00:00 EDT","open":1.02,"high":1.03,"low":0.99,"amount":91474.075572,"amplitude":0.038543,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.548863,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"listingDate":1639026000000,"exchange":"NASDAQ","adjPreClose":1.0378,"preHourTrading":{"tag":"盘前","latestPrice":1,"preClose":1.02,"latestTime":"09:11 EDT","volume":4985,"amount":5064.70018,"timestamp":1746191460345},"postHourTrading":{"tag":"盘后","latestPrice":1.03,"preClose":1.03,"latestTime":"16:13 EDT","volume":1,"amount":1.04,"timestamp":1746216821209},"volumeRatio":1.0544016514165768},"requestUrl":"/m/hq/s/NRSN","defaultTab":"news","newsList":[{"id":"2529631619","title":"Neurosense Therapeutics Ltd.盘中异动 股价大跌5.94%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529631619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529631619?lang=zh_cn&edition=full","pubTime":"2025-04-23 23:25","pubTimestamp":1745421947,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日23时25分,Neurosense Therapeutics Ltd.股票出现异动,股价急速下跌5.94%。截至发稿,该股报0.950美元/股,成交量4.1827万股,换手率0.18%,振幅4.94%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.69%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423232547a6c557dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423232547a6c557dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRSN","BK4007","BK4139"],"gpt_icon":0},{"id":"2527992449","title":"Neurosense Therapeutics Ltd.盘中异动 早盘股价大跌7.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527992449","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527992449?lang=zh_cn&edition=full","pubTime":"2025-04-15 23:04","pubTimestamp":1744729492,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日23时04分,Neurosense Therapeutics Ltd.股票出现异动,股价急速下挫7.41%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体跌幅为0.06%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415230452a459ddc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415230452a459ddc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRSN","BK4007","BK4139"],"gpt_icon":0},{"id":"2526097643","title":"Neurosense Therapeutics Ltd.盘中异动 临近收盘股价大涨8.22%报1.070美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526097643","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526097643?lang=zh_cn&edition=full","pubTime":"2025-04-12 03:53","pubTimestamp":1744401191,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日03时53分,Neurosense Therapeutics Ltd.股票出现异动,股价大幅拉升8.22%。截至发稿,该股报1.070美元/股,成交量10.2533万股,换手率0.44%,振幅7.04%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为1.89%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504120353119735a699&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504120353119735a699&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","NRSN","BK4139"],"gpt_icon":0},{"id":"2517948396","title":"Neurosense Therapeutics Ltd.盘中异动 急速拉升8.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948396","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517948396?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185111,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分,Neurosense Therapeutics Ltd.股票出现异动,股价大幅上涨8.18%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.08%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223151abe9b0bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223151abe9b0bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRSN","LENZ"],"gpt_icon":0},{"id":"2516665912","title":"Neurosense Therapeutics Ltd.盘中异动 临近收盘快速下跌5.19%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516665912","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516665912?lang=zh_cn&edition=full","pubTime":"2025-03-04 05:00","pubTimestamp":1741035611,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日05时00分,Neurosense Therapeutics Ltd.股票出现波动,股价快速下跌5.19%。截至发稿,该股报1.05美元/股,成交量19.369万股,换手率0.83%,振幅9.03%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体跌幅为0.20%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304050011abe69e8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304050011abe69e8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRSN","LENZ"],"gpt_icon":0},{"id":"2514432004","title":"Neurosense Therapeutics Ltd.盘中异动 快速上涨5.61%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514432004","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514432004?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:30","pubTimestamp":1740753024,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时30分,Neurosense Therapeutics Ltd.股票出现波动,股价快速上涨5.61%。截至发稿,该股报1.13美元/股,成交量1.564万股,换手率0.07%,振幅1.87%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.00%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223024a2580080&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223024a2580080&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRSN","BK4139","LENZ"],"gpt_icon":0},{"id":"2514801267","title":"Neurosense Therapeutics Ltd.盘中异动 快速跳水5.60%报1.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514801267","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514801267?lang=zh_cn&edition=full","pubTime":"2025-02-26 01:24","pubTimestamp":1740504293,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日01时24分,Neurosense Therapeutics Ltd.股票出现波动,股价大幅下挫5.60%。截至发稿,该股报1.02美元/股,成交量4.1206万股,换手率0.18%,振幅6.45%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.28%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226012453a253ad9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226012453a253ad9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRSN","BK4139"],"gpt_icon":0},{"id":"2512169247","title":"Neurosense Therapeutics Ltd.盘中异动 快速拉升5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512169247","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512169247?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:09","pubTimestamp":1739891370,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时09分,Neurosense Therapeutics Ltd.股票出现波动,股价快速拉升5.63%。截至发稿,该股报1.22美元/股,成交量3.3588万股,换手率0.14%,振幅4.05%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.69%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021823093096279ede&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021823093096279ede&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","NRSN"],"gpt_icon":0},{"id":"2508514259","title":"Neurosense Therapeutics Ltd.盘中异动 股价大涨6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508514259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508514259?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:48","pubTimestamp":1738594089,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时48分,Neurosense Therapeutics Ltd.股票出现波动,股价急速拉升6.00%。截至发稿,该股报1.18美元/股,成交量4.2066万股,换手率0.18%,振幅3.60%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体跌幅为0.30%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224809987971f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224809987971f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRSN","BK4139"],"gpt_icon":0},{"id":"2508994861","title":"Neurosense Therapeutics Ltd.盘中异动 下午盘快速上涨5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508994861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508994861?lang=zh_cn&edition=full","pubTime":"2025-02-01 04:00","pubTimestamp":1738353636,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日04时00分,Neurosense Therapeutics Ltd.股票出现波动,股价大幅上涨5.63%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.69%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020104003696151099&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020104003696151099&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRSN","BK4139"],"gpt_icon":0},{"id":"2506058583","title":"Neurosense Therapeutics Ltd.盘中异动 下午盘股价大跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506058583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506058583?lang=zh_cn&edition=full","pubTime":"2025-01-28 02:25","pubTimestamp":1738002359,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日02时25分,Neurosense Therapeutics Ltd.股票出现波动,股价急速下挫5.45%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.72%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280225599874d2ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280225599874d2ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRSN","LENZ","BK4139"],"gpt_icon":0},{"id":"2505861513","title":"Neurosense Therapeutics Ltd.盘中异动 股价大跌6.19%报1.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505861513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505861513?lang=zh_cn&edition=full","pubTime":"2025-01-24 23:03","pubTimestamp":1737731017,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日23时03分,Neurosense Therapeutics Ltd.股票出现波动,股价快速跳水6.19%。截至发稿,该股报1.06美元/股,成交量3.3792万股,换手率0.15%,振幅3.45%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体跌幅为0.55%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124230337a22e6177&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124230337a22e6177&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRSN","BK4139"],"gpt_icon":0},{"id":"2505706824","title":"Neurosense Therapeutics Ltd.盘中异动 临近收盘急速下挫5.31%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505706824","media":"市场透视","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505706824?lang=zh_cn&edition=full","pubTime":"2025-01-23 04:48","pubTimestamp":1737578921,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日04时48分,Neurosense Therapeutics Ltd.股票出现异动,股价大幅下挫5.31%。截至发稿,该股报1.07美元/股,成交量12.353万股,换手率0.53%,振幅5.31%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体跌幅为0.48%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123044841abb4f154&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123044841abb4f154&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRSN","BK4139"],"gpt_icon":0},{"id":"2504816019","title":"Neurosense Therapeutics Ltd.盘中异动 早盘大幅下跌5.36%报1.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504816019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504816019?lang=zh_cn&edition=full","pubTime":"2025-01-17 23:26","pubTimestamp":1737127593,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日23时26分,Neurosense Therapeutics Ltd.股票出现波动,股价快速下跌5.36%。截至发稿,该股报1.06美元/股,成交量2.521万股,换手率0.11%,振幅3.57%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为1.00%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117232633abaebd57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117232633abaebd57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRSN"],"gpt_icon":0},{"id":"2504593945","title":"Neurosense Therapeutics Ltd.盘中异动 急速拉升5.31%报1.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504593945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504593945?lang=zh_cn&edition=full","pubTime":"2025-01-17 01:54","pubTimestamp":1737050070,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日01时54分,Neurosense Therapeutics Ltd.股票出现波动,股价大幅拉升5.31%。截至发稿,该股报1.09美元/股,成交量6.1213万股,换手率0.26%,振幅6.75%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体跌幅为0.17%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501170154309868b495&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501170154309868b495&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRSN","BK4139"],"gpt_icon":0},{"id":"2501771703","title":"Neurosense Therapeutics Ltd.盘中异动 股价大跌6.42%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501771703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501771703?lang=zh_cn&edition=full","pubTime":"2025-01-08 23:31","pubTimestamp":1736350279,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日23时31分,Neurosense Therapeutics Ltd.股票出现异动,股价大幅下跌6.42%。截至发稿,该股报1.11美元/股,成交量2.0949万股,换手率0.09%,振幅2.95%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.28%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108233119aba359b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108233119aba359b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRSN","BK4139"],"gpt_icon":0},{"id":"2501552812","title":"Neurosense Therapeutics Ltd.盘中异动 早盘快速拉升5.04%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501552812","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501552812?lang=zh_cn&edition=full","pubTime":"2025-01-06 22:31","pubTimestamp":1736173911,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日22时31分,Neurosense Therapeutics Ltd.股票出现异动,股价急速拉升5.04%。截至发稿,该股报1.25美元/股,成交量1.5929万股,换手率0.07%,振幅0.00%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体跌幅为0.27%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223151aba08873&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223151aba08873&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRSN","LENZ"],"gpt_icon":0},{"id":"2500437521","title":"Neurosense Therapeutics Ltd.盘中异动 股价大涨6.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500437521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500437521?lang=zh_cn&edition=full","pubTime":"2025-01-04 00:15","pubTimestamp":1735920951,"startTime":"0","endTime":"0","summary":"北京时间2025年01月04日00时15分,Neurosense Therapeutics Ltd.股票出现异动,股价急速拉升6.96%。截至发稿,该股报1.23美元/股,成交量1.1673万股,换手率0.05%,振幅6.09%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.48%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104001551a2147f01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104001551a2147f01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRSN","BK4139"],"gpt_icon":0},{"id":"2500661044","title":"Neurosense Therapeutics Ltd.盘中异动 大幅下挫5.24%报1.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500661044","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500661044?lang=zh_cn&edition=full","pubTime":"2025-01-01 01:10","pubTimestamp":1735665004,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日01时10分,Neurosense Therapeutics Ltd.股票出现波动,股价大幅下跌5.24%。截至发稿,该股报1.18美元/股,成交量6.8288万股,换手率0.30%,振幅8.47%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.21%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010101100495f44d31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010101100495f44d31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRSN","LENZ"],"gpt_icon":0},{"id":"2493765146","title":"Neurosense Therapeutics Ltd.股价重挫19.49% 市值跌493.55万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493765146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493765146?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:35","pubTimestamp":1734964517,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时35分,Neurosense Therapeutics Ltd.股票出现异动,股价大幅下跌19.49%。截至发稿,该股报1.10美元/股,成交量23.3355万股,换手率1.01%,振幅19.04%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中,整体涨幅为0.14%。Neurosense Therapeutics Ltd.公司简介:NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司,专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法,这些疾病包括肌萎缩性侧索硬化症,阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223522a2050bb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223522a2050bb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRSN","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neurosense-tx.com","stockEarnings":[{"period":"1week","weight":0.0301},{"period":"1month","weight":0.1213},{"period":"3month","weight":-0.0721},{"period":"6month","weight":-0.1889},{"period":"1year","weight":-0.189},{"period":"ytd","weight":-0.1417}],"compareEarnings":[{"period":"1week","weight":0.0293},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0583},{"period":"6month","weight":-0.0075},{"period":"1year","weight":0.1222},{"period":"ytd","weight":-0.033}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NeuroSense Therapeutics Ltd.于2017年2月13日在以色列注册成立。该公司是一家临床阶段的生物技术公司,专注于发现和开发针对神经退行性疾病患者的治疗方法,包括肌萎缩性侧索硬化症(ALS)、阿尔茨海默病(AD)和帕金森病(PD)。公司的主要候选治疗药物PrimeC是一种新型的缓释口服制剂,由两种FDA批准的药物环丙沙星和塞来昔布组成的固定剂量组合。PrimeC旨在通过调节microRNA合成、铁积累和神经炎症来治疗ALS,所有这些都是ALS病理的标志。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.147166},{"month":2,"riseRate":0.75,"avgChangeRate":0.233386},{"month":3,"riseRate":0.5,"avgChangeRate":0.079885},{"month":4,"riseRate":0.5,"avgChangeRate":-0.151693},{"month":5,"riseRate":0.25,"avgChangeRate":-0.134354},{"month":6,"riseRate":0.666667,"avgChangeRate":0.463109},{"month":7,"riseRate":0,"avgChangeRate":-0.298623},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.020927},{"month":9,"riseRate":0.333333,"avgChangeRate":0.033411},{"month":10,"riseRate":0,"avgChangeRate":-0.15772},{"month":11,"riseRate":0.666667,"avgChangeRate":0.553258},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.152602}],"exchange":"NASDAQ","name":"Neurosense Therapeutics Ltd","nameEN":"Neurosense Therapeutics Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Neurosense Therapeutics Ltd(NRSN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Neurosense Therapeutics Ltd(NRSN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Neurosense Therapeutics Ltd,NRSN,Neurosense Therapeutics Ltd股票,Neurosense Therapeutics Ltd股票老虎,Neurosense Therapeutics Ltd股票老虎国际,Neurosense Therapeutics Ltd行情,Neurosense Therapeutics Ltd股票行情,Neurosense Therapeutics Ltd股价,Neurosense Therapeutics Ltd股市,Neurosense Therapeutics Ltd股票价格,Neurosense Therapeutics Ltd股票交易,Neurosense Therapeutics Ltd股票购买,Neurosense Therapeutics Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Neurosense Therapeutics Ltd(NRSN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Neurosense Therapeutics Ltd(NRSN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}